RECURSION PHARMACEUTICALS, INC. (RXRX)

About RECURSION PHARMACEUTICALS, INC.

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Headquarters: Salt Lake City, UT · Employees: 600 · Website: https://www.recursion.com

Related Macro Trends

• Gene Therapy & Precision Medicine
• Robotics & Industrial Automation

Product categories

• Cell Culture Media & Reagents
• Machine Vision Systems
• Industrial Robotics
• Cloud Computing
• AI GPUs
• Drug Discovery & Development

Supply-chain relationships for RXRX

• THERMO FISHER SCIENTIFIC INC. (TMO) — supplier
• Bayer AG (BAYN.DE) — partner

Competitors of RECURSION PHARMACEUTICALS, INC.

• ELI LILLY & Co (LLY)
• JOHNSON & JOHNSON (JNJ)
• AbbVie Inc. (ABBV)
• Merck & Co., Inc. (MRK)
• NOVO NORDISK A S (NVO)
• AMGEN INC (AMGN)
• PFIZER INC (PFE)
• Bayer Aktiengesellschaft (1BAYN.MI)
• IQVIA HOLDINGS INC. (IQV)
• Medpace Holdings, Inc. (MEDP)
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
• ICON PLC (ICLR)

Frequently asked questions about RECURSION PHARMACEUTICALS, INC. (RXRX)

What is RECURSION PHARMACEUTICALS, INC. (RXRX)?

RECURSION PHARMACEUTICALS, INC. (RXRX) is a publicly traded company in the Biological Products, (No Diagnostic Substances) sector (Biotechnology), listed on Nasdaq. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are RECURSION PHARMACEUTICALS, INC.'s key suppliers and customers?

Macroplane tracks RECURSION PHARMACEUTICALS, INC.'s (RXRX) supply chain. Key suppliers include THERMO FISHER SCIENTIFIC INC. (TMO).

Who are RECURSION PHARMACEUTICALS, INC.'s main competitors?

Competitors of RECURSION PHARMACEUTICALS, INC. (RXRX) tracked by Macroplane include ELI LILLY & Co (LLY), JOHNSON & JOHNSON (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), NOVO NORDISK A S (NVO), AMGEN INC (AMGN), PFIZER INC (PFE), Bayer Aktiengesellschaft (1BAYN.MI), and 4 more.